Score Breakdown
Offering Ability
46
Cash Runway
10
Float Risk
90
Warrant Exposure
30
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
📜 Warrant Exercise
model 15%
• Warrant overhang: 9.1% of shares outstanding
Market Data
Market Cap$447.83M
Shares Outstanding20.01M
Float6.01M
Cash$225.39M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 13.3% shares (2026Q1 vs prior)
98 institutional holders · 18.82M shares
#1
SAMSARA BIOCAPITAL, LLC
1.72M shares
#2
Redmile Group, LLC
1.46M shares
#3
Casdin Capital, LLC
1.42M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest3.01M
Days to Cover16.1
% of Float50.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2023-12-31
xbrl
XBRL WARRANT
2023-12-18
4
INSIDER TRANSACTION
2026-03-30
4
INSIDER TRANSACTION
2026-03-30
4
INSIDER TRANSACTION
2026-03-30
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual NGNE Dilution Snapshot
Neurogene Inc. (NGNE) has a DilutionScore of 46/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 1.8M.
- Recent SEC activity tracked for NGNE: 4 on 2026-03-30; 4 on 2026-03-30; 4 on 2026-03-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: